LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG

Published:2019-10 Issue: Volume:118 Page:109382
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Pu Yan,Dong Zhihong,Xia Yu,Zhang Mengmeng,Song Jianzhong,Han Jing,Liu Huibin

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference27 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. LncRNA CCAT1 inhibits cell apoptosis of renal cell carcinoma through up-regulation of Livin protein;Chen;Mol. Cell. Biochem.,2017

3. Systemic therapy in renal cell carcinoma: advancing paradigms;Posadas;Oncology (Williston Park, N.Y.),2012

4. The noncoding RNA revolution-trashing old rules to forge new ones;Cech;Cell.,2014

5. lncRNA-mediated regulation of the interferon response;Valadkhan;Virus Res.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular mechanism of NF-κB dysregulation across different subtypes of renal cell carcinoma;Journal of Advanced Research;2024-07

2. Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-04-18

3. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance;Pharmacological Research;2022-12

4. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer;Cellular Immunology;2022-02

5. HDAC1 promotes the migration of human myeloma cells via regulation of the lncRNA/Slug axis;International Journal of Molecular Medicine;2021-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3